2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Buy
74
GEN Quote, Financials, Valuation and Earnings
Last price:
$28.47
Seasonality move
:
0.4%
Day range:
$27.96 - $28.53
52-week range:
$22.74 - $31.72
Dividend yield:
1.76%
P/E ratio:
27.38x
P/S ratio:
4.52x
P/B ratio:
7.79x
Volume:
13M
Avg. volume:
4.8M
1-year change:
15.87%
Market cap:
$17.7B
Revenue:
$3.9B
EPS (TTM):
$1.04
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.8B | $3.3B | $3.8B | $3.9B | |
| Revenue Growth (YoY) | 2.45% | 9.6% | 18.63% | 14.56% | 3.55% | |
| Cost of Revenues | $362M | $408M | $589M | $731M | $776M | |
| Gross Profit | $2.2B | $2.4B | $2.7B | $3.1B | $3.2B | |
| Gross Profit Margin | 85.81% | 85.41% | 82.24% | 80.76% | 80.28% | |
| R&D Expenses | $267M | $253M | $313M | $332M | $329M | |
| Selling, General & Admin | $791M | $1B | $968M | $1.3B | $1B | |
| Other Inc / (Exp) | -$45M | $132M | -$106M | -$76M | -$41M | |
| Operating Expenses | $1.1B | $1.4B | $1.5B | $1.9B | $1.5B | |
| Operating Income | $1.1B | $1B | $1.3B | $1.2B | $1.6B | |
| Net Interest Expenses | $140M | $126M | $386M | $644M | $550M | |
| EBT. Incl. Unusual Items | $872M | $1B | $783M | $447M | $1B | |
| Earnings of Discontinued Ops. | -$142M | -- | -- | -- | -- | |
| Income Tax Expense | $176M | $206M | -$551M | -$160M | $386M | |
| Net Income to Company | $554M | $836M | $1.3B | $607M | $643M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $554M | $836M | $1.3B | $607M | $643M | |
| Basic EPS (Cont. Ops) | $0.94 | $1.44 | $2.17 | $0.95 | $1.04 | |
| Diluted EPS (Cont. Ops) | $0.92 | $1.41 | $2.14 | $0.95 | $1.03 | |
| Weighted Average Basic Share | $589M | $581M | $614M | $637M | $617M | |
| Weighted Average Diluted Share | $600M | $591M | $624M | $642M | $624M | |
| EBITDA | $1.2B | $1.3B | $1.5B | $1.6B | $2B | |
| EBIT | $1B | $1.2B | $1.2B | $1.1B | $1.6B | |
| Revenue (Reported) | $2.6B | $2.8B | $3.3B | $3.8B | $3.9B | |
| Operating Income (Reported) | $1.1B | $1B | $1.3B | $1.2B | $1.6B | |
| Operating Income (Adjusted) | $1B | $1.2B | $1.2B | $1.1B | $1.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $672M | $716M | $926M | $964M | $1B | |
| Revenue Growth (YoY) | 9.45% | 6.55% | 29.33% | 4.1% | 4.77% | |
| Cost of Revenues | $99M | $101M | $190M | $190M | $199M | |
| Gross Profit | $573M | $615M | $736M | $774M | $811M | |
| Gross Profit Margin | 85.27% | 85.89% | 79.48% | 80.29% | 80.3% | |
| R&D Expenses | $68M | $59M | $88M | $80M | $81M | |
| Selling, General & Admin | $200M | $398M | $237M | $226M | $263M | |
| Other Inc / (Exp) | $38M | -$9M | -$44M | -$53M | -$9M | |
| Operating Expenses | $288M | $479M | $386M | $356M | $388M | |
| Operating Income | $285M | $136M | $350M | $418M | $423M | |
| Net Interest Expenses | $34M | $31M | $163M | $153M | $127M | |
| EBT. Incl. Unusual Items | $289M | $96M | $143M | $212M | $287M | |
| Earnings of Discontinued Ops. | -$14M | -- | -- | -- | -- | |
| Income Tax Expense | $81M | -$24M | -$757M | $81M | $145M | |
| Net Income to Company | $194M | $120M | $900M | $131M | $142M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $194M | $120M | $900M | $131M | $142M | |
| Basic EPS (Cont. Ops) | $0.33 | $0.21 | $1.43 | $0.21 | $0.23 | |
| Diluted EPS (Cont. Ops) | $0.33 | $0.20 | $1.42 | $0.21 | $0.23 | |
| Weighted Average Basic Share | $583M | $581M | $641M | $628M | $614M | |
| Weighted Average Diluted Share | $588M | $591M | $645M | $636M | $624M | |
| EBITDA | $361M | $159M | $437M | $484M | $526M | |
| EBIT | $324M | $127M | $311M | $373M | $422M | |
| Revenue (Reported) | $672M | $716M | $926M | $964M | $1B | |
| Operating Income (Reported) | $285M | $136M | $350M | $418M | $423M | |
| Operating Income (Adjusted) | $324M | $127M | $311M | $373M | $422M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.8B | $3.3B | $3.8B | $3.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $362M | $408M | $589M | $731M | $776M | |
| Gross Profit | $2.2B | $2.4B | $2.7B | $3.1B | $3.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $267M | $253M | $313M | $332M | $329M | |
| Selling, General & Admin | $791M | $1B | $968M | $1.3B | $1B | |
| Other Inc / (Exp) | -$45M | $132M | -$106M | -$76M | -$41M | |
| Operating Expenses | $1.1B | $1.4B | $1.5B | $1.9B | $1.5B | |
| Operating Income | $1.1B | $1B | $1.3B | $1.2B | $1.6B | |
| Net Interest Expenses | $140M | $126M | $386M | $644M | $550M | |
| EBT. Incl. Unusual Items | $872M | $1B | $783M | $447M | $1B | |
| Earnings of Discontinued Ops. | -$142M | -- | -- | -- | -- | |
| Income Tax Expense | $176M | $206M | -$551M | -$160M | $386M | |
| Net Income to Company | $554M | $836M | $1.3B | $607M | $643M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $554M | $836M | $1.3B | $607M | $643M | |
| Basic EPS (Cont. Ops) | $0.94 | $1.44 | $2.16 | $0.95 | $1.04 | |
| Diluted EPS (Cont. Ops) | $0.93 | $1.41 | $2.12 | $0.95 | $1.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.2B | $1.3B | $1.5B | $1.6B | $2B | |
| EBIT | $1B | $1.2B | $1.2B | $1.1B | $1.6B | |
| Revenue (Reported) | $2.6B | $2.8B | $3.3B | $3.8B | $3.9B | |
| Operating Income (Reported) | $1.1B | $1B | $1.3B | $1.2B | $1.6B | |
| Operating Income (Adjusted) | $1B | $1.2B | $1.2B | $1.1B | $1.6B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $3.3B | $3.8B | $3.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $408M | $589M | $731M | $776M | -- | |
| Gross Profit | $2.4B | $2.7B | $3.1B | $3.2B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $253M | $313M | $332M | $329M | -- | |
| Selling, General & Admin | $1B | $968M | $1.3B | $1B | -- | |
| Other Inc / (Exp) | $132M | -$106M | -$76M | -$41M | -- | |
| Operating Expenses | $1.4B | $1.5B | $1.9B | $1.5B | -- | |
| Operating Income | $1B | $1.3B | $1.2B | $1.6B | -- | |
| Net Interest Expenses | $126M | $386M | $644M | $550M | -- | |
| EBT. Incl. Unusual Items | $1B | $783M | $447M | $1B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $206M | -$551M | -$160M | $386M | -- | |
| Net Income to Company | $836M | $1.3B | $607M | $643M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $836M | $1.3B | $607M | $643M | -- | |
| Basic EPS (Cont. Ops) | $1.44 | $2.16 | $0.95 | $1.04 | -- | |
| Diluted EPS (Cont. Ops) | $1.41 | $2.12 | $0.95 | $1.04 | -- | |
| Weighted Average Basic Share | $2.3B | $2.5B | $2.5B | $2.5B | -- | |
| Weighted Average Diluted Share | $2.4B | $2.5B | $2.6B | $2.5B | -- | |
| EBITDA | $1.3B | $1.5B | $1.6B | $2B | -- | |
| EBIT | $1.2B | $1.2B | $1.1B | $1.6B | -- | |
| Revenue (Reported) | $2.8B | $3.3B | $3.8B | $3.9B | -- | |
| Operating Income (Reported) | $1B | $1.3B | $1.2B | $1.6B | -- | |
| Operating Income (Adjusted) | $1.2B | $1.2B | $1.1B | $1.6B | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $933M | $1.9B | $750M | $846M | $1B | |
| Short Term Investments | $18M | $4M | -- | -- | -- | |
| Accounts Receivable, Net | $117M | $120M | $168M | $163M | $171M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $95M | $107M | $122M | $142M | $136M | |
| Other Current Assets | $15M | $24M | $23M | $17M | $18M | |
| Total Current Assets | $1.5B | $2.3B | $1.2B | $1.4B | $1.4B | |
| Property Plant And Equipment | $154M | $134M | $119M | $117M | $109M | |
| Long-Term Investments | $185M | $178M | $176M | $136M | $109M | |
| Goodwill | $2.9B | $2.9B | $10.2B | $10.2B | $10.2B | |
| Other Intangibles | $1.1B | $1B | $3.1B | $2.6B | $2.3B | |
| Other Long-Term Assets | $46M | $46M | $47M | $66M | $40M | |
| Total Assets | $6.4B | $6.9B | $15.9B | $15.8B | $15.5B | |
| Accounts Payable | $52M | $63M | $77M | $66M | $94M | |
| Accrued Expenses | $235M | $443M | $455M | $316M | $181M | |
| Current Portion Of Long-Term Debt | $313M | $1B | $233M | $175M | $291M | |
| Current Portion Of Capital Lease Obligations | $26M | $18M | $26M | $13M | $14M | |
| Other Current Liabilities | -- | -- | -- | -- | $515M | |
| Total Current Liabilities | $2.1B | $3.1B | $2.8B | $2.7B | $2.9B | |
| Long-Term Debt | $3.3B | $2.7B | $9.5B | $8.4B | $8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.9B | $7B | $13.7B | $13.7B | $13.2B | |
| Common Stock | $2.2B | $1.9B | $2.8B | $2.2B | $2.1B | |
| Other Common Equity Adj | $47M | -$4M | -$15M | $11M | -$33M | |
| Common Equity | -$500M | -$93M | $2.2B | $2.1B | $2.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$500M | -$93M | $2.2B | $2.1B | $2.3B | |
| Total Liabilities and Equity | $6.4B | $6.9B | $15.9B | $15.8B | $15.5B | |
| Cash and Short Terms | $951M | $1.9B | $750M | $846M | $1B | |
| Total Debt | $3.6B | $3.7B | $9.8B | $8.6B | $8.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $933M | $1.9B | $750M | $846M | $1B | |
| Short Term Investments | $18M | $4M | -- | -- | -- | |
| Accounts Receivable, Net | $117M | $120M | $168M | $163M | $171M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $95M | $107M | $122M | $142M | $136M | |
| Other Current Assets | $15M | $24M | $23M | $17M | $18M | |
| Total Current Assets | $1.5B | $2.3B | $1.2B | $1.4B | $1.4B | |
| Property Plant And Equipment | $154M | $134M | $119M | $117M | $109M | |
| Long-Term Investments | $185M | $178M | $176M | $136M | $109M | |
| Goodwill | $2.9B | $2.9B | $10.2B | $10.2B | $10.2B | |
| Other Intangibles | $1.1B | $1B | $3.1B | $2.6B | $2.3B | |
| Other Long-Term Assets | $46M | $46M | $47M | $66M | $40M | |
| Total Assets | $6.4B | $6.9B | $15.9B | $15.8B | $15.5B | |
| Accounts Payable | $52M | $63M | $77M | $66M | $94M | |
| Accrued Expenses | $235M | $443M | $455M | $316M | $181M | |
| Current Portion Of Long-Term Debt | $313M | $1B | $233M | $175M | $291M | |
| Current Portion Of Capital Lease Obligations | $26M | $18M | $26M | $13M | $14M | |
| Other Current Liabilities | -- | -- | -- | -- | $515M | |
| Total Current Liabilities | $2.1B | $3.1B | $2.8B | $2.7B | $2.9B | |
| Long-Term Debt | $3.3B | $2.7B | $9.5B | $8.4B | $8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.9B | $7B | $13.7B | $13.7B | $13.2B | |
| Common Stock | $2.2B | $1.9B | $2.8B | $2.2B | $2.1B | |
| Other Common Equity Adj | $47M | -$4M | -$15M | $11M | -$33M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$500M | -$93M | $2.2B | $2.1B | $2.3B | |
| Total Liabilities and Equity | $6.4B | $6.9B | $15.9B | $15.8B | $15.5B | |
| Cash and Short Terms | $951M | $1.9B | $750M | $846M | $1B | |
| Total Debt | $3.6B | $3.7B | $9.8B | $8.6B | $8.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $554M | $836M | $1.3B | $607M | $643M | |
| Depreciation & Amoritzation | $150M | $140M | $329M | $485M | $419M | |
| Stock-Based Compensation | $81M | $70M | $134M | $138M | $133M | |
| Change in Accounts Receivable | $3M | -$9M | $11M | $7M | -$53M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $706M | $974M | $757M | $2.1B | $1.2B | |
| Capital Expenditures | $6M | $6M | $6M | $20M | $15M | |
| Cash Acquisitions | -$344M | -$39M | -$6.5B | -- | -$84M | |
| Cash From Investing | -$69M | $326M | -$6.5B | $2M | -$100M | |
| Dividends Paid (Ex Special Dividend) | -$373M | -$303M | -$314M | -$323M | -$313M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $750M | $512M | $9B | -- | $941M | |
| Long-Term Debt Repaid | -$1.9B | -$541M | -$3B | -$1.2B | -$1.3B | |
| Repurchase of Common Stock | -$304M | -- | -$904M | -$441M | -$272M | |
| Other Financing Activities | -$59M | -$15M | -$20M | -$26M | -$26M | |
| Cash From Financing | -$1.9B | -$333M | $4.7B | -$2B | -$970M | |
| Beginning Cash (CF) | $2.2B | $933M | $1.9B | $750M | $846M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.3B | $967M | -$1.1B | $105M | $151M | |
| Ending Cash (CF) | $933M | $1.9B | $750M | $846M | $1B | |
| Levered Free Cash Flow | $700M | $968M | $751M | $2B | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $194M | $120M | $900M | $131M | $142M | |
| Depreciation & Amoritzation | $37M | $32M | $126M | $111M | $104M | |
| Stock-Based Compensation | $15M | $19M | $39M | $31M | $36M | |
| Change in Accounts Receivable | $2M | -$11M | $3M | -- | -$19M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $356M | $326M | $324M | $1.4B | $473M | |
| Capital Expenditures | $1M | $2M | $1M | $3M | $3M | |
| Cash Acquisitions | -$344M | -- | -- | -- | -$84M | |
| Cash From Investing | -$233M | $10M | -$1M | -$2M | -$83M | |
| Dividends Paid (Ex Special Dividend) | -$73M | -$73M | -$80M | -$78M | -$77M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$12M | -$150M | -$309M | -$658M | -$1.2B | |
| Repurchase of Common Stock | -$166M | -- | -- | -$300M | -- | |
| Other Financing Activities | -$2M | -- | -- | -$1M | -$1M | |
| Cash From Financing | -$245M | -$217M | -$383M | -$1B | -$296M | |
| Beginning Cash (CF) | $1B | $1.8B | $812M | $490M | $883M | |
| Foreign Exchange Rate Adjustment | $9M | -$3M | -$2M | -$9M | $29M | |
| Additions / Reductions | -$122M | $119M | -$60M | $365M | $94M | |
| Ending Cash (CF) | $933M | $1.9B | $750M | $846M | $1B | |
| Levered Free Cash Flow | $355M | $324M | $323M | $1.4B | $470M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $554M | $836M | $1.3B | $607M | $643M | |
| Depreciation & Amoritzation | $150M | $140M | $329M | $485M | $419M | |
| Stock-Based Compensation | $81M | $70M | $134M | $138M | $133M | |
| Change in Accounts Receivable | $3M | -$9M | $11M | $7M | -$53M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $706M | $974M | $757M | $2.1B | $1.2B | |
| Capital Expenditures | $6M | $6M | $6M | $20M | $15M | |
| Cash Acquisitions | -$344M | -$39M | -$6.5B | -- | -$84M | |
| Cash From Investing | -$69M | $326M | -$6.5B | $2M | -$100M | |
| Dividends Paid (Ex Special Dividend) | -$373M | -$303M | -$314M | -$323M | -$313M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $750M | $512M | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.9B | -$541M | -$3B | -$1.2B | -$1.3B | |
| Repurchase of Common Stock | -- | -- | -$904M | -$441M | -$272M | |
| Other Financing Activities | -$59M | -$15M | -$20M | -$26M | -$26M | |
| Cash From Financing | -$1.9B | -$333M | $4.7B | -$2B | -$970M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.3B | $967M | -$1.1B | $105M | $151M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $700M | $968M | $751M | $2B | $1.2B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $836M | $1.3B | $607M | $643M | -- | |
| Depreciation & Amoritzation | $140M | $329M | $485M | $419M | -- | |
| Stock-Based Compensation | $70M | $134M | $138M | $133M | -- | |
| Change in Accounts Receivable | -$9M | $11M | $7M | -$53M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $974M | $757M | $2.1B | $1.2B | -- | |
| Capital Expenditures | $6M | $6M | $20M | $15M | -- | |
| Cash Acquisitions | -$39M | -$6.5B | -- | -$84M | -- | |
| Cash From Investing | $326M | -$6.5B | $2M | -$100M | -- | |
| Dividends Paid (Ex Special Dividend) | -$303M | -$314M | -$323M | -$313M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $512M | $9B | -- | -- | -- | |
| Long-Term Debt Repaid | -$541M | -$3B | -$1.2B | -$1.3B | -- | |
| Repurchase of Common Stock | -- | -$904M | -$441M | -$272M | -- | |
| Other Financing Activities | -$15M | -$20M | -$26M | -$26M | -- | |
| Cash From Financing | -$333M | $4.7B | -$2B | -$970M | -- | |
| Beginning Cash (CF) | $5.5B | $5.1B | $2.5B | $3.1B | -- | |
| Foreign Exchange Rate Adjustment | -$13M | -$28M | -$9M | $9M | -- | |
| Additions / Reductions | $967M | -$1.1B | $105M | $151M | -- | |
| Ending Cash (CF) | $6.4B | $3.9B | $2.6B | $3.3B | -- | |
| Levered Free Cash Flow | $968M | $751M | $2B | $1.2B | -- | |
Get GEN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GEN
Sector
P/E ratio
27.38x
22.66x
PEG ratio
2.89x
0.01x
P/B ratio
7.79x
2.18x
Price / LTM sales
4.52x
1.53x
Growth Metrics
GEN
Sector
Revenue growth
4.77%
3.98%
Earnings growth
9.52%
12.51%
Revenue (5-year growth)
9.59%
6.64%
Earnings forecast
$0.58
$0.11
Profitability
GEN
Sector
Profitability FY 2024
$3.2B
$83M
Return on invested capital
6.06%
0.48%
Return on assets
4.15%
-0.25%
Return on equity
30.25%
0.91%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Aug
5
Balance Sheet
GEN
Sector
Total cash
$1B
$53.1M
Short term investments
--
$19.1M
Total assets
$15.5B
$239.8M
Long term debt
$8.3B
$6.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
